Zai Lab Limited Share Price Hong Kong S.E.
Stocks
9688
KYG9887T1168
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.96 HKD | -0.20% |
|
+7.55% | +9.60% |
| 16/06 | Zai Lab Receives EU Orphan Drug Designation for Lung Cancer Drug | MT |
| 10/06 | Asian Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading | MT |
| Market Cap | 214.82Cr 1.68TCr 187.8Cr 172.59Cr 160.87Cr 305.13Cr 20TCr 309.75Cr 2.07TCr 805.46Cr 10TCr 806.36Cr 789.04Cr 35TCr | P/E 2026 * |
-8.63x | P/E 2027 * | -10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 170.51Cr 1.34TCr 149.06Cr 136.99Cr 127.69Cr 242.19Cr 16TCr 245.86Cr 1.64TCr 639.31Cr 7.98TCr 640.02Cr 626.28Cr 27TCr | EV / Sales 2026 * |
3.8x | EV / Sales 2027 * | 2.96x |
| Free-Float |
95.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Zai Lab Limited
| 1 day | -0.20% | ||
| 1 week | +7.55% | ||
| Current month | +3.46% | ||
| 1 month | +12.82% | ||
| 3 months | -5.20% | ||
| 6 months | +10.16% | ||
| Current year | +9.60% |
| 1 week | 13.74 |  | 15.55 |
| 1 month | 12.49 | | 15.55 |
| Current year | 12.31 | | 20.42 |
| 1 year | 12.31 | | 32.35 |
| 3 years | 10.56 | | 35.5 |
| 5 years | 10.56 | | 142 |
| 10 years | 10.56 | | 151.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ying Du
CEO | Chief Executive Officer | 61 | 01/04/2014 |
Ya jing Chen
DFI | Director of Finance/CFO | 58 | 07/07/2023 |
Rafael Amado
PSD | President | 62 | 01/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ying Du
CHM | Chairman | 61 | 01/04/2014 |
John Diekman
BRD | Director/Board Member | 83 | 01/01/2017 |
Peter Wirth
BRD | Director/Board Member | 75 | 01/01/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.20% | +7.55% | - | - | 214.82Cr | |
| +4.73% | +3.38% | +19.53% | -8.89% | 6.66TCr | |
| -1.93% | +0.39% | +53.64% | +226.01% | 5.65TCr | |
| +1.07% | +42.10% | +42.10% | +42.10% | 4.3TCr | |
| +3.45% | +6.04% | -49.82% | -55.95% | 4.05TCr | |
| +3.04% | +0.04% | +62.66% | -24.29% | 3.19TCr | |
| +10.01% | +18.57% | +161.59% | -34.48% | 3.16TCr | |
| +2.68% | +2.73% | +70.72% | +88.24% | 2.33TCr | |
| +2.87% | +16.83% | +1.86% | +165.26% | 1.95TCr | |
| -0.13% | +2.75% | +66.32% | +127.01% | 1.72TCr | |
| Average | +2.56% | +8.76% | +47.62% | +58.33% | 3.67TCr | |
| Weighted average by Cap. | +2.77% | +7.31% | +42.61% | +52.47% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 45Cr 351.92Cr 39Cr 36Cr 34Cr 64Cr 4.27TCr 65Cr 432.76Cr 168.23Cr 2.1TCr 168.42Cr 164.81Cr 7.24TCr | 60Cr 467.13Cr 52Cr 48Cr 45Cr 85Cr 5.67TCr 86Cr 574.42Cr 223.3Cr 2.79TCr 223.55Cr 218.75Cr 9.61TCr |
| Net income | -24Cr -188.94Cr -21Cr -19Cr -18Cr -34Cr -2.29TCr -35Cr -232.34Cr -90Cr -1.13TCr -90Cr -88Cr -3.89TCr | -16Cr -122.72Cr -14Cr -13Cr -12Cr -22Cr -1.49TCr -23Cr -150.91Cr -59Cr -732.32Cr -59Cr -57Cr -2.52TCr |
| Net Debt | -44Cr -347.56Cr -39Cr -36Cr -33Cr -63Cr -4.22TCr -64Cr -427.39Cr -166.15Cr -2.07TCr -166.33Cr -162.76Cr -7.15TCr | -39Cr -303.68Cr -34Cr -31Cr -29Cr -55Cr -3.69TCr -56Cr -373.44Cr -145.17Cr -1.81TCr -145.34Cr -142.22Cr -6.24TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | HK$14.96 | -0.20% | 1,04,33,609 |
| 02/26/02 | HK$14.99 | +3.67% | 1,39,16,119 |
| 30/26/30 | HK$14.46 | +1.76% | 89,03,610 |
| 29/26/29 | HK$14.21 | +2.16% | 1,16,45,300 |
| 26/26/26 | HK$13.91 | -3.87% | 1,32,36,847 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ZLAB Stock
- 9688 Stock
Select your edition
All financial news and data tailored to specific country editions
